Litcius/Paper detail

Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients

Shaghayegh Haghjooy Javanmard, Golnaz Vaseghi, Amirreza Manteghinejad, Maryam Nasirian

2020Journal of Global Antimicrobial Resistance19 citationsDOIOpen Access PDF

Abstract

• Controlling age and sex, NLR>6.5 increases the chance of disease severity by 4 times. • NLR>6.5 increases the chance of death about 1.8 times after age and sex adjustments. • The average value of WBC among severe patients was higher than non-severe.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)BiomarkerMedicineDiseaseNeutrophil to lymphocyte ratioLymphocyteInternal medicine2019-20 coronavirus outbreakSeverity of illnessSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyPathologyBiologyInfectious disease (medical specialty)BiochemistryOutbreakCOVID-19 Clinical Research StudiesInflammatory Biomarkers in Disease PrognosisLong-Term Effects of COVID-19
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients | Litcius